INOZYME PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
INOZYME PHARMA, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 4.77 million shares as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2025-03-10
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.77M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.37M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.23M shares.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.97M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2024-12-31 | 4.77M shares 10-K · filed 2025-03-10 |
| 2023-12-31 | 3.37M shares 10-K · filed 2024-03-12 |
| 2022-12-31 | 2.23M shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 1.97M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 1.80M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 1.49M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 1.43M shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 1.23M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 1.16M shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 1.00M shares 10-Q · filed 2021-05-12 |
| 2020-12-31 | 835.77K shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 698.83K shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 544.38K shares 10-Q · filed 2020-09-03 |
| 2019-12-31 | 521.33K shares 10-Q · filed 2020-09-03 |